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Background
Penicillin allergy is reported by 10% of the population [1].
The associated morbidity is substantial given its medical
and economic implications [2-4]. The aim of this study
was to assess the quality of care with regards to the man-
agement of penicillin allergy in a university affiliated gen-
eral hospital with no allergy service.
Material and methods
All admissions from December 1
st 2008 to December 1
st
2009 were hand reviewed for a notion of penicillin
allergy. Files were then assessed for (1) quality of allergic
history to penicillin, (2) referral to an allergy clinic upon
discharge, (3) indications for such a referral, (4) indica-
tion for a beta-lactam, and in the latter case, (5) man-
agement of antibiotic therapy.
Results
Of the 1738 files reviewed, 172 contained a notion of
alleged penicillin allergy. History of the reaction to peni-
cillin was poorly detailed ev e nw h e np a t i e n t sr e q u i r e d
beta-lactam therapy (table 1). In the 87 patients who did
require a beta-lactam, half received it without any skin
testing, challenge or desensitization. No adverse reaction
occurred. The main antibiotics used in the remaining
patients were fluoroquinolones and vancomycin. Deci-
sion-making concerning the choice of antibiotic was
documented in only 18%. Upon discharge, only two
patients were referred to an allergy clinic for elective
penicillin skin testing, even though referral was strongly
indicated in 97 patients (table 2).
Conclusion
Penicillin allergy is a frequent problem in hospital prac-
tice. Its management is not optimal in most cases. This
study stresses the importance of continuous medical
education on this subject and the importance of a read-
ily available inpatient allergy service to support hospital
practitioners.
* Correspondence: beginphil@gmail.com
1Department of medicine, Hôpital Maisonneuve-Rosemont, Université de
Montréal, Montreal, Canada, H1T 2M4
Full list of author information is available at the end of the article
Table 1 Details included in allergy history
All patients
(n=172)
Patients with indication for
beta-lactam (n=87)
Allergy to penicillin noted
in admission note
139 (81%) 69 (79%)
Allergy tag on file 119 (69%) 66 (76%)
Molecule specified 31 (18%) 23 (26%)
Allergic reaction described 52 (30%) 27 (31%)
Delay since reaction noted 7 (4%) 5 (6%)
Treatment of allergic
reaction noted
00
Table 2 Strong arguments for allergy referral.
Argument Number of patient (n=172)
Allergy to a non beta-lactam antibiotic 37 (22%)
Immunosuppressive treatment 15 (9%)
Chronic disease (COPD, CKD on dialysis,
complicated diabetes)
85 (49%)
Admitted for acute infection 72 (42%)
Planned surgery 49 (28%)
Any 128 (74%)
Any and survived hospitalisation 97 (56%)
Bégin et al. Allergy, Asthma & Clinical Immunology 2010, 6(Suppl 2):P1
http://www.aacijournal.com/content/6/S2/P1 ALLERGY, ASTHMA & CLINICAL 
IMMUNOLOGY
© 2010 Bégin and Picard; licensee BioMed Central Ltd.Author details
1Department of medicine, Hôpital Maisonneuve-Rosemont, Université de
Montréal, Montreal, Canada, H1T 2M4.
2Department of medicine, Centre
Hospitalier de l’Université de Montréal, Montreal, Canada, H2L 4M1.
Published: 4 November 2010
References
1. Solensky R: Hypersensitivity reactions to beta-lactam antibiotics. Clin Rev
Allergy Immunol 2003, 24:201-20.
2. Lee CE, et al: The incidence of antimicrobial allergies in hospitalized
patients: implications regarding prescribing patterns and emerging
bacterial resistance. Arch Intern Med 2000, 160:2819-22.
3. MacLaughlin EJ, Saseen JJ, Malone DC: Costs of beta-lactam allergies:
selection and costs of antibiotics for patients with a reported beta-
lactam allergy. Arch Fam Med 2000, 9:722-6.
4. Martinez LA: Role of environmental contamination as a risk factor for
acquisition of vancomycin-resistant enterococci in patients treated in a
medical intensive care unit. Arch Intern Med 2003, 163:1905-12.
doi:10.1186/1710-1492-6-S2-P1
Cite this article as: Bégin et al.: Quality of penicillin allergy management
in the intensive care unit and internal medicine ward. Allergy, Asthma &
Clinical Immunology 2010 6(Suppl 2):P1.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Bégin et al. Allergy, Asthma & Clinical Immunology 2010, 6(Suppl 2):P1
http://www.aacijournal.com/content/6/S2/P1
Page 2 of 2